Pharmacyclics LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersSouth San Francisco, CA
US patents198
SAM.gov UEIV48MZQZHNR65
CAGE code7N4W0
Incorporated inCA
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
198 US patents granted 1996–2023, 5 of them in the five years to SEP 2025.
Pharmaceuticals 180Organic fine chemistry 12Measurement 4Medical technology 2
- Use of inhibitors of Brutons tyrosine kinase (Btk)US 11,672,803 · granted JUN 13, 2023
- Crystalline forms of a Bruton's tyrosine kinase inhibitorUS 10,961,251 · granted MAR 30, 2021
- Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK)US 10,954,567 · granted MAR 23, 2021
- Salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the sameUS 10,898,461 · granted JAN 26, 2021
- Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitorUS 10,828,259 · granted NOV 10, 2020
Newest 5 shown · Granted to Pharmacyclics LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Pharmacyclics LLC | South San Francisco | CA | — | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.